This inventor holds 1 USPTO granted patent. Top assignee: Albert-Ludwigs-Universitaet Freiburg. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Johannes Kuehle and His Patent in Cancer Immunotherapy.
Introduction
Johannes Kuehle is an inventor associated with Cologne, Germany, and Albert-Ludwigs-Universitaet Freiburg. His patent work includes an invention concerning chimeric antigen receptors that bind to prostate-specific membrane antigen.
Latest Patents
Kuehle is listed as an inventor on 1 patent: “Chimeric Antigen Receptors That Bind to Prostate Specific Membrane Antigen.” The invention focuses on engineered receptors designed to recognize prostate-specific membrane antigen, a target relevant to cancer research and immunotherapy.
Career Highlights
The available information identifies Kuehle’s patent activity and his association with Albert-Ludwigs-Universitaet Freiburg. His listed invention reflects research in the field of engineered immune-cell therapies.
Collaborations
Kuehle’s listed coworkers include Toni Cathomen and Jamal Alzubi. Their names are associated with the same patent-related research area.
Conclusion
Johannes Kuehle’s recorded patent contribution centers on chimeric antigen receptors targeting prostate-specific membrane antigen, connecting his work with cancer immunotherapy research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile